Indoco Remedies Q2 Results FY27: PAT Rs 30.63 Cr Against Loss Last Year, Revenue Rs 451.59 Cr
- October 27, 2026
- Posted by: Harsh Piplani
- Category: Results
Quick Answer
Indoco Remedies Q2 Results FY27 were declared on 27 October 2026 and show revenue of Rs 451.59 Cr, down 6.83% from Rs 484.67 Cr in the same quarter last year. Net profit came in at Rs 30.63 Cr against a loss of Rs 7.93 Cr a year earlier. These quarterly results pair a lower top line with a profit, and the YoY growth figure for net profit is 486.25% because the base was a loss.
Indoco Remedies Ltd (INDOCO) Q2 Results FY27 announced on 27 October 2026, covering the company’s financial performance for the July to September quarter. The results date brought revenue of Rs 451.59 Cr and net profit of Rs 30.63 Cr into view, and Indoco Remedies Q2 Results FY27 set both lines against the same quarter of the previous year. Readers can follow the company on the Univest app.
This results analysis of Indoco Remedies Q2 Results walks through the financial highlights, the business factors behind the numbers, the outlook for FY27 and the risks that investors may want to track. It starts with the Financial Highlights table that follows.
Click Here – Get Free Investment Predictions
Indoco Remedies Q2 Results FY27: Financial Highlights
| Metric | Q2 FY27 (Sep 26) | Q2 FY26 (Sep 25) | YoY Change |
|---|---|---|---|
| Revenue | Rs 451.59 Cr | Rs 484.67 Cr | -6.83% YoY |
| Net Profit (PAT) | Rs 30.63 Cr | Rs -7.93 Cr | +486.25% YoY |
Source: company filing for Indoco Remedies Q2 Results FY27, 27 October 2026. Figures in Rs Crore.
Key Takeaways from Indoco Remedies Q2 Results: What Stands Out
- Revenue fell 6.83% YoY to Rs 451.59 Cr from Rs 484.67 Cr in the same quarter last year, a decline of Rs 33.08 Cr in absolute terms.
- Net profit reached Rs 30.63 Cr against a net loss of Rs 7.93 Cr a year earlier, which gives YoY growth of 486.25% on a negative base.
- Net profit margin rose to 6.8% from -1.6% in the comparison quarter, so Indoco Remedies Q2 Results FY27 combine lower revenue with a higher margin.
- Return on capital employed was 0.79% in FY26 against -0.43% in FY25, while return on equity was -10.13% in FY26.
- The performance analysis comes next, where the revenue move and the net profit move are read together for the quarter.
Indoco Remedies Q2 Results FY27: Performance Analysis
Indoco Remedies Q2 Results show revenue of Rs 451.59 Cr for the July to September 2026 quarter, down 6.83% YoY from Rs 484.67 Cr, while net profit was Rs 30.63 Cr against a loss of Rs 7.93 Cr a year earlier. Revenue and net profit therefore moved in opposite directions on a YoY basis.
Indoco Remedies Q2 Results FY27 show a Rs 33.08 Cr fall in revenue alongside a Rs 38.56 Cr rise in net profit, since the loss of Rs 7.93 Cr became a profit of Rs 30.63 Cr. This results analysis treats the 486.25% YoY growth in net profit as a move from a negative base, which makes the percentage large.
Looking at Indoco Remedies Q2 Results FY27 through margins, the net profit margin of 6.8% compares with -1.6% in the comparison quarter. The data confirms what changed but does not establish the specific cause, so the quarterly results are read next through the disclosed business factors, which is where the business factors take over.
Check the Univest Screener for live results data
Key Business Factors This Quarter
Return to Net Profit – The business factors behind these quarterly results start with the swing in net profit, as the company returned to a net profit of Rs 30.63 Cr from a loss in the comparison quarter. In Indoco Remedies Q2 Results FY27, this swing is the largest single change in the numbers.
Net Profit Margin – Net profit margin improved to 6.8% from -1.6% in the comparison quarter. This margin shift took place while revenue declined 6.83% YoY, so the improvement reflects profit relative to revenue and not higher sales.
Return on Capital Employed – Return on capital employed improved to 0.79% in FY26 from -0.43% in FY25. This is a full-year measure, so it describes FY26 and not the July to September quarter, and it sits alongside the quarterly figures.
FY27 Outlook After Indoco Remedies Q2 Results
The FY27 outlook depends on the quarters still to be reported. Indoco Remedies Q2 Results FY27 cover a single quarter, and the full-year results will depend on subsequent quarters and disclosed sector conditions rather than on this filing alone.
A results analysis for the rest of FY27 can track whether net profit stays near Rs 30.63 Cr or moves with revenue, which fell 6.83% YoY this quarter. Investors can follow each new filing in the Univest app, and the figures also bring a set of risks that come next.
Key Risks to Watch After Indoco Remedies Q2 Results FY27
Revenue Decline
Revenue declined 6.8% year on year to Rs 451.59 Cr in the latest quarter. Net profit rose while revenue fell, and Indoco Remedies Q2 Results FY27 leave the revenue trend as the first item to monitor in later YoY growth comparisons.
Low Returns on Equity and Capital
Return on equity was low at -10.13% in FY26, and return on capital employed was modest at 0.79% in FY26. Both are full-year ratios and they sit beside the quarter’s net profit of Rs 30.63 Cr.
High Debt Level
Debt is high at 1.11 times total assets in FY26. A debt level above total assets is a balance sheet fact that investors may weigh alongside the quarter’s profit and the 6.83% revenue decline.
Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.
Conclusion
Indoco Remedies Q2 Results FY27 record revenue of Rs 451.59 Cr, down 6.83% YoY, and net profit of Rs 30.63 Cr against a loss a year earlier. The quarterly results therefore pair lower sales with a profit. Indoco Remedies Q2 Results are best read with the risks above and the Univest Screener, and investors should consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.
Frequently Asked Questions on Indoco Remedies Q2 Results FY27
What are Indoco Remedies Q2 Results FY27?
Ans. Indoco Remedies Q2 Results FY27 cover the July to September 2026 quarter, with revenue of Rs 451.59 Cr and net profit of Rs 30.63 Cr, while the Quick Answer box at the top of the article summarises both figures.
What is the results date for Indoco Remedies Q2 Results FY27?
Ans. Indoco Remedies declared its Q2 FY27 numbers on 27 October 2026, which is the results date for the quarter, so the opening paragraphs place revenue and net profit against that date.
What revenue was reported in Indoco Remedies Q2 Results FY27?
Ans. Indoco Remedies reported revenue of Rs 451.59 Cr in Q2 FY27, compared with Rs 484.67 Cr a year earlier, which means revenue fell by Rs 33.08 Cr, as the Financial Highlights table shows.
What net profit was reported in Indoco Remedies Q2 Results FY27?
Ans. Indoco Remedies reported net profit of Rs 30.63 Cr in Q2 FY27 against a loss of Rs 7.93 Cr a year earlier, so net profit moved by Rs 38.56 Cr, as the Performance Analysis explains.
How much YoY growth did revenue show in Indoco Remedies Q2 Results FY27?
Ans. Indoco Remedies revenue changed by -6.83% YoY in Q2 FY27, so it declined rather than grew, while net profit moved from a loss to Rs 30.63 Cr, as the Key Takeaways section notes.
Did net profit rise or fall in Indoco Remedies Q2 Results?
Ans. Net profit rose to Rs 30.63 Cr from a loss of Rs 7.93 Cr, a YoY growth figure of 486.25%, which means the percentage reflects a move from a negative base, as the Performance Analysis explains.
What was the net profit margin in Indoco Remedies Q2 Results FY27?
Ans. Indoco Remedies posted a net profit margin of 6.8% in Q2 FY27, up from -1.6% in the comparison quarter, so profit relative to revenue rose even as revenue declined, as the Key Business Factors section describes.
What were the return ratios after Indoco Remedies Q2 Results?
Ans. Return on capital employed was 0.79% in FY26 against -0.43% in FY25, while return on equity was -10.13% in FY26, so both full-year ratios are also covered in the Key Risks section.
What business factors shaped Indoco Remedies Q2 Results FY27?
Ans. The business factors are the return to a net profit of Rs 30.63 Cr, the net profit margin of 6.8% and the higher return on capital employed, which the Key Business Factors section explains in turn.
What are the key risks after Indoco Remedies Q2 Results FY27?
Ans. The risks are the 6.83% YoY revenue decline, return on equity of -10.13% and debt at 1.11 times total assets in FY26, so the Key Risks section covers each of them in turn.
What is the outlook after Indoco Remedies Q2 Results?
Ans. The FY27 outlook depends on the quarters still to be reported, because full-year results will follow subsequent quarters and disclosed sector conditions, which is why the FY27 Outlook section avoids any forecast.
Where can I find the complete Indoco Remedies Q2 Results FY27 data?
Ans. The complete figures sit in the Financial Highlights table of this article, while the Univest Screener lets you open the Indoco Remedies stock page for further details on the company.
